Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report

Uneventful benznidazole treatment of acute Chagas disease during pregnancy: a case report

This report describes the case of a patient with acute Chagas disease in Tocantins, Brazil, who was unaware of her pregnancy during benznidazole treatment. She presented with impaired cardiac function during the acute phase (pericarditis and incomplete right bundle-branch block) that resolved favora...

Full description

Bibliographic Details
Main Authors:	Valeria Rita Corrêa, Fernanda Gama Barbosa, Claudimar Américo de Melo Junior, Luis Fernando D'Albuquerque e Castro, Heitor Franco de Andrade Junior, Nanci Nascimento
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2014-06-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Acute Chagas disease Benznidazole Pregnancy
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822014000300397&lng=en&tlng=en

Similar Items

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole
by: Marisa Liliana Fernández, et al.
Published: (2016-03-01)

Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
by: Cristina Vázquez, et al.
Published: (2023-01-01)

Benznidazole vs benznidazole in multilamellar liposomes: how different they interact with blood components?
by: Maria Jose Morilla, et al.
Published: (2005-04-01)

Parasitemia and antibody response to benznidazole treatment in a cohort of patients with chronic Chagas disease
by: Carlos Henrique Valente Moreira, et al.
Published: (2023-09-01)

Benznidazole levels in blood vary with age in rats
by: Romina Fernanda Bulffer, et al.
Published: (2011-05-01)

Trypanosoma cruzi benznidazole susceptibility in vitro does not predict the therapeutic outcome of human Chagas disease
by: Margoth Moreno, et al.
Published: (2010-11-01)

Pharmacogenomic Profile and Adverse Drug Reactions in a Prospective Therapeutic Cohort of Chagas Disease Patients Treated with Benznidazole
by: Lucas A. M. Franco, et al.
Published: (2021-02-01)

Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil
by: Maria Katarine Costa Lucas Gontijo, et al.
Published: (2020-01-01)

Evaluation of parasitemia by qPCR in patients with chronic Chagas disease treated with benznidazole
by: Bianca Sabaini Pavan Tycha, et al.
Published: (2023-01-01)

Estudo comparativo controlado com emprego de benznidazole, nifurtimox e placebo, na forma crônica da doença de Chagas, em uma área de campo com transmissão interrompida. I. Avaliação preliminar
by: José Rodrigues Coura, et al.
Published: (1997-04-01)

Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens
by: André Pires Antunes, et al.

Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects
by: María Montalto de Mecca, et al.
Published: (2008-09-01)

Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
by: Davi Alvarenga Lima, et al.
Published: (2023-05-01)

Poly-ε-Caprolactone Implants for Benznidazole Prolonged Release: An Alternative to Chagas Disease Oral Treatment
by: Ana Lia Mazzeti, et al.
Published: (2023-04-01)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
by: María Cecilia Albareda, et al.
Published: (2015-05-01)

Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
by: Miriam Rolon, et al.
Published: (2022-08-01)

Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial
by: Anis Rassi Jr, et al.

A serological, parasitological and clinical evaluation of untreated Chagas disease patients and those treated with benznidazole before and thirteen years after intervention
by: Girley Francisco Machado-de-Assis, et al.
Published: (2013-11-01)

Benznidazole Treatment: Time- and Dose-Dependence Varies with the <i>Trypanosoma cruzi</i> Strain
by: Kátia da Silva Fonseca, et al.
Published: (2021-06-01)

Evaluation of in vitro anti-Trypanosoma cruzi activity of medications benznidazole, amiodarone hydrochloride, and their combination
by: Angela Maria Lourenço, et al.

Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America
by: Eloan Pinheiro, et al.

Serological based monitoring of a cohort of patients with chronic Chagas disease treated with benznidazole in a highly endemic area of northern Argentina
by: Leticia L Niborski, et al.
Published: (2016-06-01)

In vitro and in vivo experimental models for drug screening and development for Chagas disease
by: Alvaro José Romanha, et al.
Published: (2010-03-01)

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
by: J Antonio Marin-Neto, et al.
Published: (2009-07-01)

A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole
by: Bianca Zingales, et al.
Published: (2015-05-01)

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up
by: CD Fernandes, et al.
Published: (2009-02-01)

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras
by: Josep M Escribà, et al.
Published: (2009-11-01)

Benznidazole-induced genotoxicity in diploid cells of Aspergillus nidulans
by: Edilson N Kaneshima, et al.
Published: (2005-05-01)

Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies
by: Giuliana Muraca, et al.
Published: (2023-07-01)

Short-course Benznidazole treatment to reduce Trypanosoma cruzi parasitic load in women of reproductive age (BETTY): a non-inferiority randomized controlled trial study protocol
by: María L. Cafferata, et al.
Published: (2020-08-01)

In Vitro Benznidazole and Nifurtimox Susceptibility Profile of Trypanosoma cruzi Strains Belonging to Discrete Typing Units TcI, TcII, and TcV
by: Susana Revollo, et al.
Published: (2019-10-01)

Comparisons between Crystallography Data and Theoretical Parameters and the Formation of Intramolecular Hydrogen Bonds: Benznidazole
by: Boaz G. Oliveira, et al.
Published: (2016-05-01)

Variation in susceptibility to benznidazole in isolates derived from Trypanosoma cruzi parental strains
by: Veloso VM, et al.
Published: (2001-01-01)

Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole
by: Virginia G Perdomo, et al.

Acute chagas outbreaks: molecular and biological features of Trypanosoma cruzi isolates, and clinical aspects of acute cases in Santander, Colombia
by: Martha Lucía Díaz, et al.
Published: (2015-11-01)

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment
by: Marta de Lana, et al.
Published: (2009-12-01)

Unveiling challenges in real-time PCR strategies for detecting treatment failure: observations from clinical trials on chronic Chagas disease
by: Alejandro G. Schijman
Published: (2023-09-01)

Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease
by: Jaquelline Carla Valamiel de Oliveira-Silva, et al.
Published: (2015-02-01)

Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
by: Elena Aguilera, et al.

Trypanosoma cruzi: parasite antigens sequestered in heart interstitial dendritic cells are related to persisting myocarditis in benznidazole-treated mice
by: Renata Siqueira Portella, et al.
Published: (2009-11-01)